NINGBO INNO PHARMCHEM CO.,LTD. is pleased to announce the availability of high-purity 4-[5-[3-Chloro-5-(Trifluoromethyl)Phenyl]-4,5-Dihydro-5-(Trifluoromethyl)-3-Isoxazolyl]-1-Naphthalenecarboxylic Acid, a key intermediate for the synthesis of Afoxolaner. With the CAS Registry Number 1308362-48-2, this compound is a critical component in the pharmaceutical value chain, specifically for the production of active pharmaceutical ingredients (APIs) used in veterinary medicine.

Afoxolaner is a widely recognized and effective parasiticide, primarily utilized in formulations for the treatment and prevention of flea and tick infestations in dogs. Its efficacy and safety profile have made it a cornerstone in companion animal health. The quality and consistency of the intermediates used in its synthesis are paramount to ensuring the final API meets stringent regulatory standards and delivers the expected therapeutic outcomes. NINGBO INNO PHARMCHEM CO.,LTD. understands this critical need and provides this intermediate with a guaranteed purity of greater than 98%, ensuring it serves as a reliable starting material for subsequent synthesis steps.

The chemical structure of this intermediate is defined by the formula C22H12ClF6NO3 and a molecular weight of 487.78 g/mol. Known by several synonyms, including 4-(5-(3-Chloro-5-(Trifluoromethyl)Phenyl)-5-(Trifluoromethyl)-4,5-Dihydroisoxazol-3-yl)-1-Naphthoic Acid, its complex structure is essential for building the final Afoxolaner molecule. As an intermediate, it typically exists as a powder or crystalline solid, suitable for standard pharmaceutical processing techniques.

NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing high-quality pharmaceutical intermediates and fine chemicals. The production of 4-[5-[3-Chloro-5-(Trifluoromethyl)Phenyl]-4,5-Dihydro-5-(Trifluoromethyl)-3-Isoxazolyl]-1-Naphthalenecarboxylic Acid adheres to rigorous quality control standards at every stage of the manufacturing process. From raw material sourcing to final product analysis, the company employs sophisticated analytical methods to confirm identity, purity, and other critical specifications. This dedication to quality ensures that pharmaceutical manufacturers can rely on the consistency and performance of the intermediate supplied.

The global demand for effective veterinary parasiticides continues to grow, driven by increasing pet ownership and a focus on animal health and welfare. This creates a sustained need for reliable suppliers of key intermediates like CAS 1308362-48-2. Pharmaceutical companies engaged in the synthesis of Afoxolaner require a partner capable of providing consistent supply, technical support, and materials that meet global pharmaceutical standards. NINGBO INNO PHARMCHEM CO.,LTD. aims to be that partner, offering not just a product, but a dependable link in the supply chain.

The intermediate is available in standard pharmaceutical packaging formats, such as bottles and barrels, suitable for transportation and storage in compliance with chemical handling guidelines. NINGBO INNO PHARMCHEM CO.,LTD. facilitates orders with a minimum order quantity (MOQ) of 1 kg, catering to both R&D scale projects and initial production batches. The company maintains a production capacity designed to meet the evolving needs of the market, ensuring availability for its customers.

Using high-purity intermediates is crucial not only for achieving the desired yield and purity of the final API but also for minimizing impurities that could impact the safety and efficacy of the finished drug product. Regulatory bodies worldwide impose strict limits on impurities in APIs, making the quality of starting materials and intermediates non-negotiable. NINGBO INNO PHARMCHEM CO.,LTD.'s focus on producing Afoxolaner Intermediate with >98% purity directly addresses this critical requirement for its customers.

Beyond the technical specifications, NINGBO INNO PHARMCHEM CO.,LTD. understands the importance of reliable logistics and customer service. Ensuring timely delivery and providing necessary documentation, such as Certificates of Analysis and safety data sheets, are integral parts of the company's service offering. The company works to build long-term relationships with its clients by providing transparent communication and responsive support.

The applications of this intermediate are centered within the pharmaceutical industry for the synthesis of Afoxolaner. Companies involved in the development or manufacturing of veterinary APIs and finished dose forms for companion animals will find this intermediate essential. It is also valuable for research institutions and laboratories working on developing new synthetic routes or analyzing the properties of isoxazoline-based compounds.

In summary, NINGBO INNO PHARMCHEM CO.,LTD. offers a high-quality, high-purity Afoxolaner Intermediate (CAS 1308362-48-2) that is essential for the synthesis of a leading veterinary parasiticide. The company's commitment to quality, reliability, and customer service positions it as a valuable supplier in the pharmaceutical intermediate market. For pharmaceutical companies seeking a trusted manufacturer and supplier of this key intermediate, NINGBO INNO PHARMCHEM CO.,LTD. provides the quality and support needed to succeed in API production. Inquiries regarding specifications, availability, and price are welcome. To learn more or to discuss how to buy or purchase this product, interested parties are encouraged to contact NINGBO INNO PHARMCHEM CO.,LTD. directly.